Effects of Aerobic Exercise in Patients With Pre-diabetes
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
It is well known that diabetes and excessive or high blood sugars causes blood vessel and blood cell damage. It is also possible, then, that people with pre-diabetes may also start to have blood vessel and blood cell damage as the blood sugars rise from the normal range into the diabetic range. In addition to looking at potential damage, the question is whether or not this damage improves with exercise. This study aims to look at blood vessel and blood cells in three different ways by 1) looking at how the blood vessel responds to "sheer force" (a blood pressure cuff pumped up and then released after a few minutes). This is done by ultrasound. 2) By looking at blood tests such as blood sugar, cholesterol, and inflammation and 3) By looking at certain blood cells in the lab, how long they live and the number of cells left after a certain number of days, and again, if this improves with exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 9, 2013
CompletedFirst Posted
Study publicly available on registry
May 23, 2013
CompletedJuly 17, 2014
July 1, 2014
3.2 years
May 9, 2013
July 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measures of Endothelial Function by studying number, function and gene expression of endothelial progenitor cells (identified as CD34+ cells)
A. Number of viable CD34 +ve cells at Day-0 and viability assay. B. Colony Formation count assay at Day-5, pre and post exercise. C. We will test CD34+ cell migration, adhesion and tube formation properties. D. Gene expression in CD34+ cells of critical endothelial function and inflammatory genes will be measured: eNOS, vWF and PECAM1, VE-cadherin, VEGF-A, Superoxide dismutase (SOD)-1, 2 and 3, Catalase, Interleukin (IL)-6, Tumor Necrosis Factor (TNF alpha), P53, P21, PUMA, Bcl2 \[Apoptosis genes\] will also be noted
16 weeks per patient
Secondary Outcomes (1)
Measures of Vacular Reactivity
16 weeks
Other Outcomes (1)
Measures of Insulin Sensitivity by measuring inflammatory molecules as a surrogate of insulin resistance
16 weeks
Study Arms (2)
Prediabetes with exercise
OTHER150 minutes of moderate exercise per week
Prediabetes without exercise
OTHERPre-study activity level (i.e. no exercise)
Interventions
Eligibility Criteria
You may qualify if:
- Prediabetic
- Impaired fasting glucose (100-125mg/dl)
- Impaired glucose tolerance (2' post between 140-199mg/dl)
- HbA1C 5.7-6.4 mg/d (inclusive)
- Exercise Naive
- BMI between 20-39.9
- Nutritional Counseling prior to participation with CDE/RD
- Willing to wear activity monitor
- Willing to keep a dietary log
You may not qualify if:
- Pace maker or other implanted device that might have interference with Tanita scale
- Any contraindication to moderate exercise
- Previous coronary disease or cerebrovascular event active or clinically significant coronary vascular disease, or peripheral vascular disease
- Diabetes
- Uncontrolled hypertension (SBP \> 140 or DBP \> 90 on 3 separate occasions) ACE's or ARB's
- Premature familial CAD (Father \< 55years\_\_\_\_ Mother \<65years)
- HDL \< 40mg/dl
- Triglycerides \>400mg/dl
- Any new lipid lowering medication started in the past 6 months
- Framingham Risk Score two or more
- Smoking
- Hypertension (B/P \> 140/90 or on antihypertensives)
- HDL \< 40mg/dl
- Age men \>45years or women \>55years
- Low hematocrit ( or hemoglobinopathies that may impair exercise tolerance) or abnormal CBC
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabyasachi Sen, MD, PhD
Baystate Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Endocrinology
Study Record Dates
First Submitted
May 9, 2013
First Posted
May 23, 2013
Study Start
March 1, 2010
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
July 17, 2014
Record last verified: 2014-07